Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient PopulationInfection Control & Hospital Epidemiology, 2008
- Increase in Adult Clostridium difficile –related Hospitalizations and Case-Fatality Rate, United States, 2000–2005Emerging Infectious Diseases, 2008
- Yogurt Containing Probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 Helps Resolve Moderate Diarrhea and Increases CD4 Count in HIV/AIDS PatientsJournal of Clinical Gastroenterology, 2008
- How Science Will Help Shape Future Clinical Applications of ProbioticsClinical Infectious Diseases, 2008
- Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse modelMolecular Systems Biology, 2008
- Saccharomyces boulardiiamelioratesCitrobacter rodentium-induced colitis through actions on bacterial virulence factorsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Neues aus der Cochrane Library: Probiotika für die Prävention der kindlichen Antibiotika-assoziierten DiarrhöZeitschrift für Gastroenterologie, 2007
- Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trialBMJ, 2007
- Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea in children: a randomized double‐blind placebo‐controlled trialAlimentary Pharmacology & Therapeutics, 2005
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989